William Gerard Bornmann

Bayou Therapeutics Inc. 
anti-cancer drug design and synthesisTotal Synthesis of Natural Products
"William Bornmann"
Mean distance: 8.71
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Napier RJ, Norris BA, Swimm A, et al. (2015) Low doses of imatinib induce myelopoiesis and enhance host anti-microbial immunity. Plos Pathogens. 11: e1004770
Peng Z, Maxwell D, Sun D, et al. (2014) Design and Synthesis of an Inositol Phosphate Analog Based on Computational Docking Studies. Tetrahedron. 70: 984-990
Zhang W, Ruvolo VR, Gao C, et al. (2014) Evaluation of apoptosis induction by concomitant inhibition of MEK, mTOR, and Bcl-2 in human acute myelogenous leukemia cells. Molecular Cancer Therapeutics. 13: 1848-59
Cao L, Li LS, Spruell C, et al. (2014) Tumor-selective, futile redox cycle-induced bystander effects elicited by NQO1 bioactivatable radiosensitizing drugs in triple-negative breast cancers. Antioxidants & Redox Signaling. 21: 237-50
Peng Z, Maxwell DS, Sun D, et al. (2014) Degrasyn-like symmetrical compounds: possible therapeutic agents for multiple myeloma (MM-I). Bioorganic & Medicinal Chemistry. 22: 1450-8
Pal A, Sung B, Bhanu Prasad BA, et al. (2014) Curcumin glucuronides: Assessing the proliferative activity against human cell lines Bioorganic and Medicinal Chemistry. 22: 435-439
Peng Z, Maxwell DS, Sun D, et al. (2014) Imatinib analogs as potential agents for PET imaging of Bcr-Abl and c-KIT expression at a kinase level. Bioorganic & Medicinal Chemistry. 22: 623-32
Wu CF, Liu S, Lee YC, et al. (2014) RSK promotes G2/M transition through activating phosphorylation of Cdc25A and Cdc25B. Oncogene. 33: 2385-94
Maxwell DS, Sun D, Peng Z, et al. (2013) Synthesis of a Macrocycle Based on Linked Amino Acid Mimetics (LAAM). Tetrahedron Letters. 54: 5799-5801
Bey EA, Reinicke KE, Srougi MC, et al. (2013) Catalase abrogates β-lapachone-induced PARP1 hyperactivation-directed programmed necrosis in NQO1-positive breast cancers Molecular Cancer Therapeutics. 12: 2110-2120
See more...